Literature DB >> 29644409

Paroxetine ameliorates whole-body allodynia.

Hiroki Shiwaku1, Toru Nishikawa2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29644409     DOI： 10.1007/s00228-018-2438-0

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  5 in total

1.  A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.

Authors:  J F Wernicke; Y L Pritchett; D N D'Souza; A Waninger; P Tran; S Iyengar; J Raskin
Journal:  Neurology       Date:  2006-10-24       Impact factor: 9.910

2.  P2X4R+ microglia drive neuropathic pain.

Authors:  Simon Beggs; Tuan Trang; Michael W Salter
Journal:  Nat Neurosci       Date:  2012-07-26       Impact factor: 24.884

Review 3.  Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.

Authors:  Nanna B Finnerup; Nadine Attal; Simon Haroutounian; Ewan McNicol; Ralf Baron; Robert H Dworkin; Ian Gilron; Maija Haanpää; Per Hansson; Troels S Jensen; Peter R Kamerman; Karen Lund; Andrew Moore; Srinivasa N Raja; Andrew S C Rice; Michael Rowbotham; Emily Sena; Philip Siddall; Blair H Smith; Mark Wallace
Journal:  Lancet Neurol       Date:  2015-01-07       Impact factor: 44.182

4.  Duloxetine Inhibits Microglial P2X4 Receptor Function and Alleviates Neuropathic Pain after Peripheral Nerve Injury.

Authors:  Tomohiro Yamashita; Shota Yamamoto; Jiaming Zhang; Miho Kometani; Daisuke Tomiyama; Keita Kohno; Hidetoshi Tozaki-Saitoh; Kazuhide Inoue; Makoto Tsuda
Journal:  PLoS One       Date:  2016-10-21       Impact factor: 3.240

5.  Antidepressants inhibit P2X4 receptor function: a possible involvement in neuropathic pain relief.

Authors:  Kenichiro Nagata; Toshiyasu Imai; Tomohiro Yamashita; Makoto Tsuda; Hidetoshi Tozaki-Saitoh; Kazuhide Inoue
Journal:  Mol Pain       Date:  2009-04-23       Impact factor: 3.395
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.